X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/01/29/2818834/0/en/Carmot-Therapeutics-Announces-Completion-of-Acquisition-by-Roche.html
https://endpts.com/fractyl-health-files-for-ipo-to-back-obesity-gene-therapy-seeking-to-replicate-glp-1-success-with-one-time-treatment/
https://www.reuters.com/markets/deals/roche-acquire-carmot-therapeutics-27-bln-2023-12-04/
https://www.globenewswire.com//news-release/2023/12/04/2789690/0/en/Carmot-Therapeutics-Enters-into-Definitive-Merger-Agreement-with-Roche.html
https://endpts.com/carmot-therapeutics-files-for-ipo-as-it-pursues-obesity-and-diabetes-work/
https://www.globenewswire.com//news-release/2023/11/15/2781024/0/en/Carmot-Therapeutics-Commenced-Phase-2-Clinical-Trial-of-Novel-Dual-GLP-1-GIP-Receptor-Agonist-CT-868-for-the-Treatment-of-Type-1-Diabetes.html
https://www.globenewswire.com//news-release/2023/10/15/2760248/0/en/Carmot-Therapeutics-Highlights-Clinical-Data-from-its-Pipeline-of-Treatments-for-Obesity-and-Diabetes-at-ObesityWeek.html
https://www.globenewswire.com//news-release/2023/10/10/2757528/0/en/Carmot-Therapeutics-Announces-that-Preliminary-Phase-1-Results-Support-Once-daily-Oral-Dosing-for-its-Obesity-and-Type-2-Diabetes-Candidate-CT-996.html
https://www.globenewswire.com//news-release/2023/09/26/2749552/0/en/Carmot-Therapeutics-Announces-Two-Oral-Presentations-Featuring-Clinical-Data-from-its-Pipeline-of-Treatments-for-Obesity-and-Diabetes-at-the-59th-European-Association-for-the-Study.html
https://www.globenewswire.com/news-release/2023/07/19/2707294/0/en/Carmot-Therapeutics-Appoints-Charles-W-Newton-to-Board-of-Directors.html
Market Place
Share 
